SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2511Beat me to it. :)nigel bates-12/16/2009
2510SNNS -16%rkrw-12/16/2009
2509Addex just lost about three quarters of its value: Geneva, Switzerland, 15 Decenigel bates-12/16/2009
2508SNSS -17%.rkrw-12/15/2009
2507[t]tse:tth[/t] closed down 45% on safety related concern for highest dosages in Ian@SI-12/15/2009
2506PIP got hit a few days ago too.. Another VXGN?mlkr-12/13/2009
2505Allon [t]tse:npc[/t] off about 19% which is a nickle on heavy volume for it. OvIan@SI-12/10/2009
2504SOMX once more -64% to 1.28 stock traded below $1 briefly. >>>>>RockyBalboa-12/7/2009
2503PLX -15%, closed -13%. Maybe shareholders didn't like today's deal withtnsaf-12/1/2009
2502Hey cool, nice joke. The shoe fits kid.RockyBalboa-12/1/2009
2501siliconinvestor.com :-)DewDiligence_on_SI-12/1/2009
2500Another "biotech" chopped in half; ampligen does not work again! (HEBRockyBalboa-12/1/2009
2499Two additional news came out from PARD: better data release for another trial upmlkr-11/25/2009
2498LONDON, Nov 19 (Reuters) - Lupus specialist ImmuPharma (LSE: IMM.L - news) 'nigel bates-11/19/2009
2497CERS lost about 20%, 52c after the halt.RockyBalboa-11/17/2009
2496DCGN (predictably) files for bankruptcy. I guess Roche will pick up some pieces nigel bates-11/17/2009
2495ISIS off ~15% this morning after releasing a PR about mipomersen in connection wtuck-11/17/2009
2494Intermune (ITMN) has to ditch the high dose arm in its HCV trial due to liver totuck-11/17/2009
2493CERS which is halted (at 2.56) and will reopen today could see some selling on iRockyBalboa-11/17/2009
2492Entremed (ENMD), which has had a strong year, is off 15% after announces earningtuck-11/16/2009
2491<i>Neuromed</i> is private.DewDiligence_on_SI-11/16/2009
2490<<< <I>CRXX off 40%: CombinatoRx, Incorporated (NASDAQ: CRXX - NIan@SI-11/16/2009
2489CRXX off 40%: CombinatoRx, Incorporated (NASDAQ: CRXX - News) and Neuromed Pharnigel bates-11/16/2009
2488PARD -80% to 1.45 or so (-$6.12) on not meeting primary endpoint. Cash 1.15 BV 0RockyBalboa-11/16/2009
2487For the record Altus was a spinout from Vertex. I guess vertex knew what they werkrw-11/12/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News